BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 1825629)

  • 1. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
    Kirkhus B; Clausen OP
    Cytometry; 1990; 11(2):253-60. PubMed ID: 1690627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric BrdUrd-pulse-chase study of X-ray-induced alterations in cell cycle progression.
    Higashikubo R; Ragouzis M; Roti Roti JL
    Cell Prolif; 1996 Jan; 29(1):43-57. PubMed ID: 8603109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
    Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
    Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H; Otto U; Hatje U; Fack H
    Cytometry; 1995 Sep; 21(1):52-61. PubMed ID: 8529471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the measurement of cytokinetics by continuous labeling with bromodeoxyuridine with applications to chick wing buds.
    White RA; Fallon JF; Savage MP
    Cytometry; 1992; 13(5):553-6. PubMed ID: 1633735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the distribution of the G(2) phase duration from flow cytometric histograms.
    Larsson S; Ryden T; Holst U; Oredsson S; Johansson M
    Math Biosci; 2008 Jan; 211(1):1-17. PubMed ID: 17942127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromodeoxyuridine labeling and flow cytometric identification of replicating Saccharomyces cerevisiae cells: lengths of cell cycle phases and population variability at specific cell cycle positions.
    Dien BS; Srienc F
    Biotechnol Prog; 1991; 7(4):291-8. PubMed ID: 1367343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle analysis using numerical simulation of bivariate DNA/bromodeoxyuridine distributions.
    Yanagisawa M; Dolbeare F; Todoroki T; Gray JW
    Cytometry; 1985 Nov; 6(6):550-62. PubMed ID: 4064838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.